Skip to content
SEKISUI XenoTech DD Blog Logo

New Division Directors for Core Services and Logistics

Following the promotion of Dr. Joanna Barbara, PhD, to Vice President of Scientific Operations, Dr. Etsuko Usuki, PhD, has been promoted to the position of Division Director for SEKISUI XenoTech’s Core Services. Etsuko received her PhD in Analytical Chemistry from Virginia Polytechnic Institute and State University, and BS in Pharmaceutical Sciences from Kobegakuin University in Japan. After working as an Analytical Chemist at Takeda and Postdoctoral Research Associate at the Harvey W. Peters Center for the Study of Parkinson’s Disease (VA Tech), she joined SEKISUI XenoTech as a Senior Scientist for the Drug Metabolism Department in 1998. Dr. Usuki is responsible for directing the implementation of SEKISUI XenoTech’s quality vision throughout the Program Execution, Program Oversight and Lab Operations teams, with a focus on scientific quality in the lab, interpretation of data and study oversight.

Andrea Wolff has been appointed to the newly created position of Division Director for SEKISUI XenoTech’s Services Logistics. Andrea received her Bachelors of Science with a double major in Chemistry and Biology at Baker University and joined the SEKISUI XenoTech team in 1999. She has more than 15 years of experience with GLP and non-GLP in vitro metabolism and transporter studies at SEKISUI XenoTech. Her experience started as an analyst and then Study Director focusing on in vitro drug metabolism studies. After over 10 years focusing on in vitro metabolism, her focus shifted to in vitro drug transporter studies, serving as a Study Director and then Manager for 5 years. She then expanded her focus, managing drug interaction studies across multiple disciplines (in vitro drug metabolism, drug transporters, enzyme induction and enzyme inhibition) and providing guidance to clients on the regulatory requirements for performing in vitro drug interaction studies. Andrea now manages several core service support teams that cover protocol writing, report writing, data processing and project management. She is responsible for the quality and timelines associated with all contract study deliverables executed at SEKISUI XenoTech.

Learn more about SEKISUI XenoTech’s management team

Learn more about:

About the Authors

Michael Millhollen received his bachelor's degree in Visual Communications from the University of Kansas and has over 20 years of experience in marketing and communications. As Global Marketing Manager, he is dedicated to the objective of sharing SEKISUI XenoTech’s scientific expertise and knowledge with scientists around the world.

Subscribe to our Newsletter

Stay up to date with our news, events and research

In vitro pipette test article treatment
005 International Messaging Created with Sketch.

Do you have a question or a request for upcoming blog content?

We love to get your feedback

A scientist utlilizing a microplate